JRoon, you are correct, and it seems this predates Strength. So this started long before any data from Strength. A Canadian company Ocean Nutrition was supplying their product for this.
Recruitment occurred over a 5-year period, starting with the first patient randomized on November 28, 2013, and completed enrollment by August 2019. The results were recently published in November 2025.
After enrollment was completed , the trial ran for 3.5 yrs .
Substantial difference between this enrolled in STRENGTH vs those enrolled in PISCES
Patient Population: The PISCES trial focused on an extremely high-risk population (dialysis patients), where standard cardiovascular interventions often have limited efficacy. The STRENGTH trial focused on high-risk individuals with residual hypertriglyceridemia, a broader population.